TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29158011

Group type: EXPERIMENTAL
Intervention: Extended intermittent letrozole (2.5 mg/day orally for 9 months followed by a 3-month break in years 1-4 and then 2.5 mg/day during all 12 months of year 5)
Number of subjects: 4851

Group type: COMPARATOR
Intervention: Continuous letrozole (2.5 mg/day orally for 5 years)
Number of subjects: 4851

Group type: EXPERIMENTAL
Intervention: Both groups (intermittent and continuous letrozole)
Number of subjects: 4851
Study: 28453454

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronate and tramadol injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intra-articular hyaluronate injection alone
Number of subjects: 30
Study: 25592003

Group type: EXPERIMENTAL
Intervention: Olopatadine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fexofenadine
Number of subjects: 0
Study: 23249571

Group type: EXPERIMENTAL
Intervention: ePTFE-covered stents
Number of subjects: 37

Group type: COMPARATOR
Intervention: Uncovered stents
Number of subjects: 37
Study: 22115190

Group type: EXPERIMENTAL
Intervention: Optimized ventilation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard ventilation
Number of subjects: 70
Study: 18328348

Group type: EXPERIMENTAL
Intervention: rosiglitazone (RSG) 4 mg/d (increased to 8 mg/d after 6 months) plus glibenclamide
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo plus glibenclamide
Number of subjects: 89
Study: 17139601

Group type: EXPERIMENTAL
Intervention: Prostanoids, endothelin receptor antagonists, or phosphodiesterase 5 inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spiroergometry and Doppler stress echocardiography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment of underlying disease
Number of subjects: 0
Study: 14971794

Group type: EXPERIMENTAL
Intervention: Phentolamine 0.2 mg kg(‐1) i.v.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10352774

Group type: EXPERIMENTAL
Intervention: Cryotherapy at 10 degrees C (N = 7)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cryotherapy at 5 degrees C (N = 7)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (N = 7)
Number of subjects: 21
Study: 7860766

Group type: EXPERIMENTAL
Intervention: Group 1 (normofiltration)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Group 2 (hypofiltration)
Number of subjects: 23
Study: 2016397

Group type: EXPERIMENTAL
Intervention: Breathing teddy bear
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nonbreathing bear
Number of subjects: 45
Study: 7129723

Group type: EXPERIMENTAL
Intervention: 20% preliminary tension
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 30% preliminary tension
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 40% preliminary tension
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0% to 70% of maximal voluntary contraction value (MVC)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: RFD
Number of subjects: 13
Study: 31987228

Group type: EXPERIMENTAL
Intervention: S. officinalis extract (330 mg daily for 8 weeks)
Number of subjects: 60
Study: 29485356

Group type: EXPERIMENTAL
Intervention: 14-week corrective exercise program
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 26
Study: 28544610

Group type: EXPERIMENTAL
Intervention: Phenol-enriched virgin olive oils (FVOO) and control virgin olive oil (VOO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phenol-enriched virgin olive oil with thyme (FVOOT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control virgin olive oil (VOO)
Number of subjects: 0
Study: 24674154

Group type: EXPERIMENTAL
Intervention: Specialized coaching
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study: 24177170

Group type: EXPERIMENTAL
Intervention: Sandblasting (SA) with DMG LUXACORE Smartmix Dual
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Silanization (SI) with DMG LUXACORE Smartmix Dual
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sandblasting followed by silanization (SS) with DMG LUXACORE Smartmix Dual
Number of subjects: 80

Group type: COMPARATOR
Intervention: No pre‐treatment (NS, control) with DMG LUXACORE Smartmix Dual
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Panavia F2.0
Number of subjects: 80
Study: 23041682

Group type: COMPARATOR
Intervention: Thoracic epidural block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 19352324

Group type: EXPERIMENTAL
Intervention: VEGF gene therapy (2,000 microg of VEGF plasmid DNA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (buffered saline)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: VEGF gene therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 17445644

Group type: EXPERIMENTAL
Intervention: Prophylactic low-molecular-weight heparin for 1 week (Group 2)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Conventional heparin for 1 week (Group 3)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No heparinization (Group 1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Conventional heparin (Group 3)
Number of subjects: 75
Study: 15878544

Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 108

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) followed by acenocoumarol
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cost-analysis
Number of subjects: 108
Study: 12659411

Group type: EXPERIMENTAL
Intervention: Repeated breast-feeding counselling (once before delivery and at 1, 2, 3, 4, 5, 6, 9, and 12 months)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Single session of breast-feeding counselling (just before delivery)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Repeated breast-feeding counselling
Number of subjects: 174

Group type: COMPARATOR
Intervention: Single session of breast-feeding counselling
Number of subjects: 174
Study: 9438781

Group type: EXPERIMENTAL
Intervention: Epinephrine infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Norepinephrine infusion
Number of subjects: 8
Study: 9676668

Group type: EXPERIMENTAL
Intervention: Masked review (one reviewer received a manuscript with author identity masked)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Unmasked review (one reviewer received an unmasked manuscript)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Overall masking success
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Manuscripts by well-known authors
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Successfully masked manuscripts
Number of subjects: 118
Study: 1929613

Group type: EXPERIMENTAL
Intervention: Adjuvant radiation by the brachytherapy technique
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Eligible patients not randomized to the trial
Number of subjects: 1600
Study: 6214228

Group type: EXPERIMENTAL
Intervention: Piperacillin plus amikacin
Number of subjects: 297

Group type: COMPARATOR
Intervention: Carbenicillin plus amikacin
Number of subjects: 297
Study: 30667597

Group type: EXPERIMENTAL
Intervention: Active microcurrent emitter
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham device (placebo)
Number of subjects: 71
Study: 28119041

Group type: EXPERIMENTAL
Intervention: Capecitabine plus oxaliplatin (XELOX)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Capecitabine monotherapy (X)
Number of subjects: 50
Study: 26648706

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/formoterol (two doses)
Number of subjects: 0
Study: 23289773

Group type: EXPERIMENTAL
Intervention: Psychological preoperative program (group 1) including psychological preparation activities and psychologist's support during all phases of the operatory iter.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Distraction activities (group 2) as a control intervention.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Psychological preoperative program (group 1) for mothers' anxiety.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Psychological preoperative program (group 1) for mothers' satisfaction.
Number of subjects: 50
Study: 21621929

Group type: EXPERIMENTAL
Intervention: IBT plus acamprosate
Number of subjects: 371

Group type: COMPARATOR
Intervention: IBT plus placebo
Number of subjects: 371

Group type: COMPARATOR
Intervention: TAU plus acamprosate
Number of subjects: 371
Study: 17530622

Group type: EXPERIMENTAL
Intervention: Cognitive therapy intervention
Number of subjects: 238

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 238
Study: 16423848

Group type: EXPERIMENTAL
Intervention: Irinotecan plus carboplatin (IP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Etoposide plus carboplatin (EP)
Number of subjects: 70
Study: 12614418

Group type: EXPERIMENTAL
Intervention: Three treatments with cooled 40‐ms alexandrite laser (fluences of 16 to 24 J/cm2)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Two treatments with cooled 40‐ms alexandrite laser (fluences of 16 to 24 J/cm2)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Single treatment with cooled 40‐ms alexandrite laser (fluences of 16 to 24 J/cm2)
Number of subjects: 144
Study: 10840428

Group type: EXPERIMENTAL
Intervention: Preoperative enema
Number of subjects: 50

Group type: COMPARATOR
Intervention: No enema
Number of subjects: 50
Study: 8638803

Group type: EXPERIMENTAL
Intervention: Sevoflurane (< or = 2.4% inspired concentration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane (< or = 1.9% inspired concentration)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50
Study: 1998281

Group type: EXPERIMENTAL
Intervention: Questran Light (4 g of cholestyramine in 5 g of powder per pack)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Questran (4 g of cholestyramine in 9 g of powder per pack)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both Questran Light and Questran
Number of subjects: 61
Study: 6826532

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 60
Study: 31075171

Group type: EXPERIMENTAL
Intervention: Artesunate therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IgG3, C1q fixation, and opsonic phagocytosis seropositivity
Number of subjects: 0
Study: 29609158

Group type: EXPERIMENTAL
Intervention: Lower extremity power training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 27014821

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate + ulinastatin
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 67
Study: 24254301

Group type: EXPERIMENTAL
Intervention: Functional beverage (FB) consumed 187 mL acutely and twice a day for 15 days chronically
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control placebo beverage
Number of subjects: 26
Study: 22414847

Group type: EXPERIMENTAL
Intervention: Atmospheric pressure nonequilibrium plasmas (APNPs) for 5 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2% chlorhexidine digluconate (CHX) for 5 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atmospheric pressure nonequilibrium plasmas (APNPs) for 5, 10, and 15 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2% chlorhexidine digluconate (CHX) for 5, 10, and 15 minutes
Number of subjects: 0
Study: 20852059

Group type: EXPERIMENTAL
Intervention: Biventricular pacing with peri-infarct LV lead placement (cardiac resynchronization therapy [CRT]-D)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 80
Study: 17412965

Group type: EXPERIMENTAL
Intervention: Conceptual implicit memory measured through subjective ratings of squiggle meaningfulness and behavioral indications of memory.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit memory measured through contrasts based on meaningfulness ratings and memory judgments.
Number of subjects: 0
Study: 16354848

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Prior rehabilitation status
Number of subjects: 1218
Study: 12221737

Group type: EXPERIMENTAL
Intervention: RDC/TMD depression scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RDC/TMD non-specific physical symptoms scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RDC/TMD graded chronic pain scale
Number of subjects: 0
Study: 9736437

Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 380

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Long-acting nisoldipine
Number of subjects: 380

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 380

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 380
Study: 9125457

Group type: EXPERIMENTAL
Intervention: Linear acceleration steps of 0.05 g, 0.1 g, or 0.24 g amplitude
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Viewing earth‐fixed targets at 30 cm, 60 cm, or 280 cm
Number of subjects: 6
Study: 2576366

Group type: EXPERIMENTAL
Intervention: Picumast dihydrochloride (2 mg twice daily orally)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Ketotifen (1 mg twice daily orally)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 400
Study: 963397

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 24
Study: 28464241

Group type: EXPERIMENTAL
Intervention: PATHS Preschool Program
Number of subjects: 285
Study: 28692017

Group type: EXPERIMENTAL
Intervention: Barriers to physical activity (BPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Barriers to healthy eating (BHE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher BHE
Number of subjects: 0
Study: 26627982

Group type: EXPERIMENTAL
Intervention: Corticosteroids (IV or PO administration totaling more than 20 mg methylprednisolone equivalents during one calendar day)
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Corticosteroids use in non-survivor group
Number of subjects: 745
Study: 23417481

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21753729

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 99

Group type: COMPARATOR
Intervention: Multidisciplinary Pain Intervention (MPI) program
Number of subjects: 99
Study: 19112077

Group type: EXPERIMENTAL
Intervention: Collaborative Parent Involvement (CPI) scores at or above the median among primary caregivers
Number of subjects: 309

Group type: COMPARATOR
Intervention: Collaborative Parent Involvement (CPI) scores below the median for both caregivers
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Collaborative Parent Involvement (CPI) scores of primary caregivers
Number of subjects: 309
Study: 16945121

Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg twice daily
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg once daily
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg twice daily (severe symptoms subgroup)
Number of subjects: 457
Study: 15646158

Group type: EXPERIMENTAL
Intervention: Physicians who had heard about EBM
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Critical appraisal knowledge and EBM knowledge scores
Number of subjects: 409
Study: 11564369

Group type: EXPERIMENTAL
Intervention: Immunoablation followed by stem cell rescue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microchimerism
Number of subjects: 0
Study: 8995085

Group type: EXPERIMENTAL
Intervention: Early ERCP and papillotomy
Number of subjects: 238

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 238
Study: 8422204

Group type: EXPERIMENTAL
Intervention: Supervised resistance exercise training for 5 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 3321877

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% and 2% pilocarpine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% and 4% pilocarpine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 93
Study: 28463013

Group type: EXPERIMENTAL
Intervention: Community members' ratings of voice quality using Voice Quality/Acceptability questionnaire
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Community members' ratings of voice quality using Communicative Suitability Scale
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Community members' gender perception question
Number of subjects: 66

Group type: COMPARATOR
Intervention: Clinicians' ratings of voice quality
Number of subjects: 66

Group type: COMPARATOR
Intervention: Patients' self-rated voice quality and acceptability
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Voice acceptability ratings by community members
Number of subjects: 66
Study: 27166233

Group type: EXPERIMENTAL
Intervention: Zolpidem CR 12.5 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 24766549

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 22100963

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 100
Study: 20431394

Group type: EXPERIMENTAL
Intervention: Abacavir/Lamivudine
Number of subjects: 385

Group type: COMPARATOR
Intervention: Tenofovir/Emtricitabine
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 385
Study: 18566972

Group type: EXPERIMENTAL
Intervention: i.v. placebo administration with glucose expectation
Number of subjects: 24
Study: 15772863

Group type: EXPERIMENTAL
Intervention: 19-mg caffeine and 250-mg theobromine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 11949898

Group type: EXPERIMENTAL
Intervention: Dynamic Field Theory (DFT) predictions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moving to an 'A' location on successive trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First trial to a nearby 'B' location
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Category Adjustment (CA) model
Number of subjects: 0
Study: 10070918

Group type: EXPERIMENTAL
Intervention: Double-bag disconnect system (B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Y-set disconnect system (Y)
Number of subjects: 120
Study: 7478687

Group type: EXPERIMENTAL
Intervention: Sterile Water Injections (SWI)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Saline Injections (PSI)
Number of subjects: 117
Study: 2205255

Group type: EXPERIMENTAL
Intervention: Care from nurse practitioners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional care from family physicians
Number of subjects: 0
Study: 359067

Group type: EXPERIMENTAL
Intervention: Vincristine + DTIC + duborimycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vincristine + DTIC
Number of subjects: 0
Study: 31181657

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 28389217

Group type: EXPERIMENTAL
Intervention: 150 mg of octopamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 25731939

Group type: EXPERIMENTAL
Intervention: Participants born preterm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants born SGA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants born AGA
Number of subjects: 0
Study: 25154148

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 30
Study: 21788663

Group type: EXPERIMENTAL
Intervention: Idebenone 900 mg/day
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 18637091

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 991

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 991
Study: 17126775

Group type: EXPERIMENTAL
Intervention: Bupivacaine scalp block (SB group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline control (C group)
Number of subjects: 16
Study: 14630260

Group type: COMPARATOR
Intervention: 70 Gy
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: 78 Gy
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: 64-66 Gy
Number of subjects: 1087

Group type: EXPERIMENTAL
Intervention: 68-70 Gy
Number of subjects: 1087
Study: 10690882

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg daily)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE; 0.625 mg daily)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg daily) plus CEE (0.625 mg daily)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 425
Study: 9350365

Group type: EXPERIMENTAL
Intervention: Sevoflurane 7% with nitrous oxide 50% in oxygen for three minutes (Group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Conventional slow induction with increasing sevoflurane concentration up to 5% with nitrous oxide 50% in oxygen (Group B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Thiamylal 5 mg.kg-1 with inhalation of 100% oxygen (Group C)
Number of subjects: 24
Study: 1443509

Group type: EXPERIMENTAL
Intervention: Racemic ketamine 2 mg/kg bw
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: S-(+)-ketamine 1 mg/kg bw
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: S-(+)-ketamine 1 mg/kg bw with midazolam 0.1 mg/kg i.v.
Number of subjects: 30
Study: 2422103

Group type: EXPERIMENTAL
Intervention: Insulin plus aprotinin (10,000 KIU for every 10 U.I. insulin)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Insulin by itself
Number of subjects: 19
Study: 31331348

Group type: EXPERIMENTAL
Intervention: Non-physician clinicians (MLs) in intervention hospitals
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (hospitals without MLs)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Non-physician clinicians (MLs) and medically trained doctors (MDs) in intervention hospitals
Number of subjects: 16